SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 127 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.69 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $5,636,000 | -34.1% | 1,847,789 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $8,555,000 | -15.4% | 1,847,789 | +5.8% | 0.00% | -50.0% |
Q2 2016 | $10,109,000 | -5.7% | 1,746,011 | -1.5% | 0.00% | 0.0% |
Q1 2016 | $10,722,000 | -33.3% | 1,772,275 | +0.6% | 0.00% | -33.3% |
Q4 2015 | $16,085,000 | +64.9% | 1,761,785 | +1.9% | 0.00% | +50.0% |
Q3 2015 | $9,753,000 | -51.8% | 1,729,318 | -5.3% | 0.00% | -33.3% |
Q2 2015 | $20,246,000 | -32.5% | 1,825,637 | -4.6% | 0.00% | -40.0% |
Q1 2015 | $30,000,000 | +2.7% | 1,913,266 | -0.4% | 0.01% | 0.0% |
Q4 2014 | $29,211,000 | +38.1% | 1,920,542 | -2.1% | 0.01% | +25.0% |
Q3 2014 | $21,154,000 | -26.9% | 1,961,386 | +3.5% | 0.00% | -20.0% |
Q2 2014 | $28,942,000 | -11.8% | 1,895,324 | +4.4% | 0.01% | -16.7% |
Q1 2014 | $32,814,000 | +32.3% | 1,814,939 | +1.7% | 0.01% | +50.0% |
Q4 2013 | $24,797,000 | +36.4% | 1,785,220 | +3.0% | 0.00% | 0.0% |
Q3 2013 | $18,178,000 | +41.3% | 1,732,851 | +5.2% | 0.00% | +33.3% |
Q2 2013 | $12,864,000 | – | 1,647,125 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WASATCH ADVISORS LP | 17,986,781 | $10,788,471 | 0.07% |
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO | 254,257 | $12,790 | 0.03% |
Long Focus Capital Management, LLC | 1,372,000 | $822,926 | 0.03% |
GSA CAPITAL PARTNERS LLP | 559,731 | $336 | 0.03% |
Rokos Capital Management LLP | 6,474,348 | $3,940,936 | 0.03% |
Golden State Equity Partners | 166,265 | $99,726 | 0.03% |
State of Wyoming | 92,360 | $55,398 | 0.01% |
ExodusPoint Capital Management, LP | 1,890,425 | $1,134 | 0.01% |
ACADIAN ASSET MANAGEMENT LLC | 2,927,769 | $1,753 | 0.01% |
Fort Sheridan Advisors LLC | 53,831 | $32,288 | 0.01% |